z-logo
open-access-imgOpen Access
Timing of Bone Marrow Cell Delivery Has Minimal Effects on Cell Viability and Cardiac Recovery After Myocardial Infarction
Author(s) -
RutgerJan Swijnenburg,
Johannes A. Govaert,
Koen E.A. van der Bogt,
Jeremy I. Pearl,
Mei Huang,
William Stein,
Grant Hoyt,
Hannes Vogel,
Christopher H. Contag,
Robert C. Robbins,
Joseph C. Wu
Publication year - 2009
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.109.872085
Subject(s) - medicine , myocardial infarction , bioluminescence imaging , bone marrow , cardiac function curve , ventricle , progenitor cell , cardiology , ejection fraction , infarction , andrology , pathology , stem cell , heart failure , luciferase , biology , transfection , genetics , cell culture
Despite ongoing clinical trials, the optimal time for delivery of bone marrow mononuclear cells (BMCs) after myocardial infarction is unclear. We compared the viability and effects of transplanted BMCs on cardiac function in the acute and subacute inflammatory phases of myocardial infarction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom